Givaudan will acquire 40.6% of the shares of Naturex, a French public listed company, for €135 (US$166.28nature’s bounty zinc gluconate 10 mg 100 tablet) per share and a total consideration of €522 million.###This agreement is subject to all of the appropriate regulatory approvals.###Givaudan intends to launch a mandatory cash tender offer for all remaining outstanding shares of Naturex, at a price of €135 per share.###Naturex deals with the plant extraction and the development of natural ingredients and solutions for the food, health and beauty sectors.###It is headquarteredcitracal kosher in Avignon and reported sales of €405 million in 2017, operates from 16 production sites around the world and employs 1,700 people.###“The acquisition of a significant shareholding in Naturex fits magnesium citrate and anxietyfully with our 2020 strategy to expand our offering to deliver natural products to our customers,” said Gilles Andrier, CEO of Givaudan.###“Givaudan is the global leader in tiron content in ferrous fumaratehe space of natural flavors and Naturex further complements our capabilities with its strong portfolio of plant extracts and natural ingredients across the food and beverage, nutrition and health and personal care sectors.&ferrous fumarate iron content#8221;